GLYCEMIC CONTROL AND PERIPHERAL-NERVE CONDUCTION IN CHILDREN AND YOUNG-ADULTS AFTER 5-6 MO OF IDDM

被引:25
作者
ALLEN, C
DUCK, SC
SUFIT, RL
SWICK, HM
DALESSIO, DJ
机构
[1] UNIV WISCONSIN, SCH MED, DEPT NEUROL, MADISON, WI 53705 USA
[2] UNIV WISCONSIN, SCH MED, DEPT MED, MADISON, WI 53705 USA
[3] MED COLL WISCONSIN, DEPT PEDIAT, MILWAUKEE, WI 53226 USA
[4] MED COLL WISCONSIN, DEPT NEUROL, MILWAUKEE, WI 53226 USA
关键词
D O I
10.2337/diacare.15.4.502
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE- A cohort of people (n = 86) was examined in the first few months after insulin-dependent diabetes mellitus (IDDM) diagnosis to evaluate the effect of hyperglycemia on nerve conduction velocities and latencies. RESEARCH DESIGN AND METHODS- Unselected cases with IDDM, who were 6-29 yr of age, were identified at diagnosis from a large, geographically defined area of southern Wisconsin. Peripheral nerve conduction was measured on a sample from this cohort. RESULTS- Peroneal nerve conduction velocity was significantly inversely related to glycosylated hemoglobin (P < 0.05, age and height adjusted). All other nerve conduction velocities and latencies (median motor, median sensory, and sural) showed the same tendency, but the associations were not statistically significant. Twenty-four-hour urine C-peptide and duration of diabetes (3-11 mo) were not consistently related to nerve conduction parameters after controlling for age and height. CONCLUSIONS- These findings suggest that as early as 5-6 mo after diabetes diagnosis, and at a time frequently characterized by partial remission of IDDM, hyperglycemia has a role in the acute slowing of nerve conduction velocity. Other factors such as residual endogenous insulin production do not appear to influence these early changes.
引用
收藏
页码:502 / 507
页数:6
相关论文
共 28 条
[1]  
ALVARSSON ML, 1989, DIABETES RES CLIN EX, V10, P75
[2]   PERIPHERAL-NERVE ABNORMALITIES IN NEWLY-DIAGNOSED DIABETIC CHILDREN [J].
COMI, G ;
CANAL, N ;
LOZZA, L ;
BECCARIA, L ;
MESCHI, F ;
VANINI, R ;
DARCAIS, AF ;
CHIUMELLO, G .
ACTA DIABETOLOGICA LATINA, 1986, 23 (01) :69-75
[3]  
DAUBE J R, 1987, P162
[4]  
DCCT Res Grp, 1988, DIABETES, V37, P476
[5]  
DORMAN T, 1982, BRIT MED J, V285, P1073
[6]   24-42 MONTH STABILITY OF INTERNAL BLOOD STANDARDS FOR GLYCATED HEMOGLOBIN ANALYSIS [J].
DUCK, SC ;
LEE, M ;
DALESSIO, D .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1990, 9 (02) :195-199
[7]   ROLE OF HEIGHT AND GLYCOSYLATED HEMOGLOBIN IN ABNORMAL NERVE-CONDUCTION IN PEDIATRIC-PATIENTS WITH TYPE-I DIABETES-MELLITUS AFTER 4-9 YR OF DISEASE [J].
DUCK, SC ;
WEI, F ;
PARKE, J ;
SWICK, HM .
DIABETES CARE, 1991, 14 (05) :386-392
[8]   NEUROPATHY SYMPTOM PROFILE IN HEALTH, MOTOR-NEURON DISEASE, DIABETIC NEUROPATHY, AND AMYLOIDOSIS [J].
DYCK, PJ ;
KARNES, J ;
OBRIEN, PC ;
SWANSON, CJ .
NEUROLOGY, 1986, 36 (10) :1300-1308
[9]   CLINICAL AND NEUROPATHOLOGICAL CRITERIA FOR THE DIAGNOSIS AND STAGING OF DIABETIC POLYNEUROPATHY [J].
DYCK, PJ ;
KARNES, JL ;
DAUBE, J ;
OBRIEN, P ;
SERVICE, FJ .
BRAIN, 1985, 108 :861-880
[10]   PROGRESSION OF INCIPIENT DIABETIC-RETINOPATHY DURING GOOD GLYCEMIC CONTROL [J].
ENGERMAN, RL ;
KERN, TS .
DIABETES, 1987, 36 (07) :808-812